CONSUMER ATTITUDES TOWARDS SMART HOME TECHNOLOGIES: THE CASE OF TURKIYE
Pamukkale University Journal of Social Sciences Institute · 04.05.2026 · (74) · 269-287
DOI: 10.30794/pausbed.1755860 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pamukkale University Journal of Social Sciences Institute, online erschienen am 04.05.2026. Verfasst von Miray Baybars. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
This study aims to explain individuals' attitudes toward smart home Technologies (SHT) and their intentions to use these technologies from the perspective of a developing country, Turkiye, as an example. Based on the Technology Acceptance Model (TAM), the study analyzed the effects of perceived ease of use, environmental benefits, economic advantages, security, and cost factors on both attitudes and behavioral intentions. Data was collected through face-to-face and online surveys between June 2024 and February 2025. The findings reveal that perceived ease of use has the most significant effect on attitudes, while perceived environmental benefits influence attitudes and perceived economic advantages influence usage intentions to a greater extent. The study contributes to the extension of TAM and provides practical recommendations for the widespread adoption of smart home technologies in the context of developing countries.
Zitieren
APA
Baybars, M. (2026). CONSUMER ATTITUDES TOWARDS SMART HOME TECHNOLOGIES: THE CASE OF TURKIYE. Pamukkale University Journal of Social Sciences Institute, 269-287. https://doi.org/10.30794/pausbed.1755860
Vancouver
Baybars M. CONSUMER ATTITUDES TOWARDS SMART HOME TECHNOLOGIES: THE CASE OF TURKIYE. Pamukkale University Journal of Social Sciences Institute. 2026:269-287. doi:10.30794/pausbed.1755860
BibTeX
@article{Baybars2026,
author = {Baybars, Miray},
title = {CONSUMER ATTITUDES TOWARDS SMART HOME TECHNOLOGIES: THE CASE OF TURKIYE},
journal = {Pamukkale University Journal of Social Sciences Institute},
year = {2026},
number = {74},
pages = {269--287},
doi = {10.30794/pausbed.1755860}
}
EUVIMED